prikaz prve stranice dokumenta The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu
  Preuzmi
PDF 585.63 KB
Znanstveni rad - Izvorni znanstveni rad
The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu
Journal of Clinical Medicine, 8 (2019), 9; https://doi.org/10.3390/jcm8091413
Mahdavi Gorabi, Armita; Banach, Maciej; Reiner, Željko; Pirro, Matteo; Hajighasemi, Saeideh; Johnston, Thomas P.; Sahebkar, Amirhossein

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Mahdavi Gorabi, A., Banach, M., Reiner, Ž., Pirro, M., Hajighasemi, S., Johnston, T. P. i Sahebkar, A. (2019). The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu. Journal of Clinical Medicine, 8. (9). doi: 10.3390/jcm8091413

Mahdavi Gorabi, Armita, et al. "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu." Journal of Clinical Medicine, vol. 8, br. 9, 2019. https://doi.org/10.3390/jcm8091413

Mahdavi Gorabi, Armita, Maciej Banach, Željko Reiner, Matteo Pirro, Saeideh Hajighasemi, Thomas P. Johnston i Amirhossein Sahebkar. "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu." Journal of Clinical Medicine 8, br. 9 (2019). https://doi.org/10.3390/jcm8091413

Mahdavi Gorabi, A., et al. (2019) 'The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu', Journal of Clinical Medicine, 8(9). doi: 10.3390/jcm8091413

Mahdavi Gorabi A, Banach M, Reiner Ž, Pirro M, Hajighasemi S, Johnston TP, i sur.. The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu. Journal of Clinical Medicine [Internet]. 08.09.2019. [pristupljeno 11.05.2024.];8(9). doi: 10.3390/jcm8091413

A. Mahdavi Gorabi, et al., "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu", Journal of Clinical Medicine, vol. 8, br. 9, Rujan 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:669618. [Citirano: 11.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:669618
Podaci o radu
Naslov (engleski)The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu
AutorArmita Mahdavi Gorabi
AutorMaciej Banach
AutorŽeljko Reiner
AutorMatteo Pirro
AutorSaeideh Hajighasemi
AutorThomas P. Johnston
AutorAmirhossein Sahebkar
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Atherosclerosis is a chronic, inflammatory disease that mainly affects the arterial intima. The disease is more prevalent in middle-age and older individuals with one or more cardiovascular risk factors, including dyslipidemia, hypertension, diabetes, smoking, obesity, and others. The beginning and development of atherosclerosis has been associated with several immune components, including infiltration of inflammatory cells, monocyte/macrophage-derived foam cells, and inflammatory cytokines and chemokines. Mesenchymal stem cells (MSCs) originate from several tissue sources of the body and have self-renewal and multipotent differentiation characteristics. They also have immunomodulatory and anti-inflammatory properties. Recently, it was shown that MSCs have a regulatory role in plasma lipid levels. In addition, MSCs have shown to have promising potential in terms of treatment strategies for several diseases, including those with an inflammatory component. In this regard, transplantation of MSCs to patients with atherosclerosis has been proposed as a novel strategy in the treatment of this disease. In this review, we summarize the current advancements regarding MSCs for the treatment of atherosclerosis.
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of Clinical Medicine
Brojčani podacivol. 8, br. 9
p-ISSN2077-0383
DOIhttps://doi.org/10.3390/jcm8091413
URN:NBNurn:nbn:hr:105:669618
Datum objave publikacije2019-09-08
URL dokumentahttp://doi.org/10.3390/jcm8091413
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:37:10